Oppenhaim Eitan sold $750K of NVMI

Oppenhaim Eitan sold 1,290 shares of NOVA LTD. (NVMI) at $581.20 ($0.75M total) on 2026-06-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Oppenhaim Eitan
Published Jun 24, 2026, 6:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 24, 2026, 6:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NVMI
Neutral
medium confidence
Mentioned
$NVMI
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NVMINeutralLow
01

Why it matters

The newest fact is the reported open-market sale (1,290 shares) and the post-sale holdings (6,421 shares), under a pre-arranged 10b5-1 plan.

02

Market read

Traders may monitor for follow-on insider activity, but this specific disclosure alone is unlikely to drive a major repricing.

03

What to watch

Without context on total insider holdings, prior sale cadence, or whether other insiders also sold/bought, the signal-to-noise for price impact remains low.

Relevance 4/10Novelty 4/10Timing: Filed 2026-06-24; transaction dated 2026-06-22.

Background

The article is an SEC Form 4 insider transaction disclosure for NOVA LTD. (NVMI) by director Oppenhaim Eitan.

Company-level read

Ticker impact

$NVMINeutralMedium confidence
Context

Form 4 shows director Oppenhaim Eitan sold 1,290 NVMI shares in an open-market sale for about $749,748 on 2026-06-22.

Expected impact

Likely limited near-term impact; any effect should be small and short-lived unless followed by additional disclosures.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated 10b5-1 plan, which typically reduces interpretive signal versus discretionary selling.

Market effects

No sector-level read-across is provided; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

A large insider sale can still be interpreted as risk-reduction or liquidity needs, but the presence of a pre-arranged 10b5-1 plan weakens that inference.

Key entities

  • NVMI

    NOVA LTD., the issuer of the Form 4 insider transaction.

  • Oppenhaim Eitan

    Director who executed the reported open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVMIMed

Nova Q3 Earnings Call Highlights

Nova (NVMI) reported strong Q3 results, with record advanced packaging sales and significant demand for its WMC platform. Logic and foundry accounted for 61% of product revenue. The company forecasted Q4 revenue of $305M-$315M and expects GAAP EPS of $2.78-$2.94. Nova ended Q3 with $1.8B in cash and repurchased $38.5M of shares. It plans to discuss future strategy at an investor day in March 2027.

$NVMIMed

Nova Ltd (NVMI) Q3 2026 Earnings Call Highlights: Record Revenue, $1 Billion Milestone

Nova Ltd (NVMI) reported record Q3 2026 revenue, reaching $1 billion. The company faces supply chain constraints and expects new competition in materials metrology. Gross margin is guided to remain flat at 59%. Operating expenses are expected to increase in Q4 2026 due to higher R&D spending. CEO Gabriel Waisman highlighted growth opportunities in memory and gate-all-around metrology, with strong demand for the Metrion tool despite longer lead times.

$NVMIHighAI 8/10

Nova (NVMI) Q3 2026 Earnings Call Transcript

Nova (NVMI) reported Q3 2026 revenue of $287.8M, up 13% QoQ and 28% YoY, driven by strong demand in memory, advanced packaging, and logic segments. The company expects to exceed $1B in annual revenue, a year ahead of plan. Q4 guidance projects revenue between $305M-$315M and EPS between $2.78-$2.94 (GAAP) and $3.03-$3.18 (non-GAAP).